B.H. Rovin

1.0k total citations
14 papers, 750 citations indexed

About

B.H. Rovin is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, B.H. Rovin has authored 14 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 6 papers in Immunology and 4 papers in Nephrology. Recurrent topics in B.H. Rovin's work include Systemic Lupus Erythematosus Research (9 papers), Vitamin D Research Studies (4 papers) and Renal Diseases and Glomerulopathies (4 papers). B.H. Rovin is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Vitamin D Research Studies (4 papers) and Renal Diseases and Glomerulopathies (4 papers). B.H. Rovin collaborates with scholars based in United States, Argentina and China. B.H. Rovin's co-authors include Huijuan Song, C. Yung Yu, Lee A. Hebert, HN Nagaraja, Daniel J. Birmingham, CC Mok, Howan Leung, Betty P. Tsao, Hui Wu and Fawzi I. Irshaid and has published in prestigious journals such as Annals of the Rheumatic Diseases, American Journal of Kidney Diseases and Lara D. Veeken.

In The Last Decade

B.H. Rovin

13 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.H. Rovin United States 12 415 345 212 194 114 14 750
Christopher Collins United States 14 523 1.3× 495 1.4× 169 0.8× 74 0.4× 64 0.6× 25 930
Rajalingham Sakthiswary Malaysia 15 352 0.8× 173 0.5× 91 0.4× 34 0.2× 40 0.4× 60 701
Václav Eis Czechia 14 144 0.3× 314 0.9× 82 0.4× 211 1.1× 81 0.7× 21 830
Alvaro Gómez Sweden 17 456 1.1× 288 0.8× 98 0.5× 74 0.4× 16 0.1× 43 690
Z. Bahloul Tunisia 16 455 1.1× 256 0.7× 120 0.6× 66 0.3× 14 0.1× 140 905
Norma Uribe‐Uribe Mexico 17 184 0.4× 215 0.6× 41 0.2× 178 0.9× 41 0.4× 65 770
Noriyuki Hiramatsu Japan 9 181 0.4× 371 1.1× 86 0.4× 242 1.2× 33 0.3× 15 870
C Dostál Czechia 14 347 0.8× 209 0.6× 47 0.2× 103 0.5× 23 0.2× 37 547
DJ Wallace United States 13 555 1.3× 348 1.0× 102 0.5× 49 0.3× 14 0.1× 24 732
Takero Naito Japan 9 129 0.3× 220 0.6× 46 0.2× 294 1.5× 54 0.5× 16 636

Countries citing papers authored by B.H. Rovin

Since Specialization
Citations

This map shows the geographic impact of B.H. Rovin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.H. Rovin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.H. Rovin more than expected).

Fields of papers citing papers by B.H. Rovin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.H. Rovin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.H. Rovin. The network helps show where B.H. Rovin may publish in the future.

Co-authorship network of co-authors of B.H. Rovin

This figure shows the co-authorship network connecting the top 25 collaborators of B.H. Rovin. A scholar is included among the top collaborators of B.H. Rovin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.H. Rovin. B.H. Rovin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jayne, David, B.H. Rovin, Eduardo Mysler, et al.. (2021). POS0690 RANDOMIZED, CONTROLLED, PHASE 2 TRIAL OF TYPE 1 IFN INHIBITOR ANIFROLUMAB IN PATIENTS WITH ACTIVE PROLIFERATIVE LUPUS NEPHRITIS. Annals of the Rheumatic Diseases. 80. 592–592. 14 indexed citations
2.
Rovin, B.H., Richard Furie, Gustavo Aroca, et al.. (2020). SUN-374 B-CELL DEPLETION AND RESPONSE IN A RANDOMIZED, CONTROLLED TRIAL OF OBINUTUZUMAB FOR PROLIFERATIVE LUPUS NEPHRITIS. Kidney International Reports. 5(3). S352–S352. 5 indexed citations
3.
Cassol, Clarissa A., et al.. (2019). SAT-154 Anticoagulants and the kidney: 10 years of clinical and experimental experience. Kidney International Reports. 4(7). S69–S70.
4.
Abulaban, Khalid, Huijuan Song, Paul L. Kimmel, et al.. (2016). Predicting decline of kidney function in lupus nephritis using urine biomarkers. Lupus. 25(9). 1012–1018. 29 indexed citations
5.
Ware, Kyle, J. C. Vance, Lee A. Hebert, et al.. (2014). Oral Warfarin and the Thrombin Inhibitor Dabigatran Increase Blood Pressure in Rats: Hidden Danger of Anticoagulants?. American Journal of Hypertension. 28(2). 182–189. 20 indexed citations
6.
Malvar, Ana, et al.. (2014). The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients. Lupus. 23(8). 840–847. 69 indexed citations
7.
Song, Huijuan, et al.. (2012). Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus. 21(8). 855–864. 42 indexed citations
8.
9.
10.
Irshaid, Fawzi I., HN Nagaraja, Betty P. Tsao, et al.. (2010). The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus. 19(11). 1272–1280. 121 indexed citations
11.
Yang, Yan, Erwin K. Chung, Bi Zhou, et al.. (2003). The Intricate Role of Complement Component C4 in Human Systemic Lupus Erythematosus. PubMed. 7. 98–132. 97 indexed citations
12.
Rovin, B.H., et al.. (2001). Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta.. PubMed. 69(3). 435–9. 15 indexed citations
13.
Rovin, B.H., et al.. (1998). Chemotactic factors and renal inflammation. American Journal of Kidney Diseases. 31(6). 1065–1084. 120 indexed citations
14.
Rovin, B.H., et al.. (1998). Lymphocytes produce IL-1beta in response to Fcgamma receptor cross-linking: effects on parenchymal cell IL-8 release.. PubMed. 160(8). 3942–8. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Collins Breakdown of academic impact, for papers by Rajalingham Sakthiswary Breakdown of academic impact, for papers by Václav Eis Breakdown of academic impact, for papers by Alvaro Gómez Breakdown of academic impact, for papers by Z. Bahloul Breakdown of academic impact, for papers by Norma Uribe‐Uribe Breakdown of academic impact, for papers by Noriyuki Hiramatsu Breakdown of academic impact, for papers by C Dostál Breakdown of academic impact, for papers by DJ Wallace Breakdown of academic impact, for papers by Takero Naito
Rankless by CCL
2026